Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle

Annals of the New York Academy of Sciences

Volumn 880, Issue , 1999, Pages 31-37

  Chiao, Paul J ^a,c   Hunt, Kelly K ^a   Grau, Ana M ^b   Abramian, Aram ^a   Fleming, Jason ^a   Zhang, Wei ^a   Breslin, Tara ^d   Abbruzzese, James L ^a   Evans, Douglas B ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; COLON CANCER; CONFERENCE PAPER; HUMAN; PANCREAS CANCER; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0032788607     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09507.x     Document Type: Conference Paper

References (26)

1. 1. PARKER, S.L., T. TONG, S. BOLDEN & P.A. WINGO. 1997, Cancer Statistics, 1997. CA-. Cancer J. Clin. 47: 5-27.
2. 2. DIGIUSEPPE, J.A., C.J. YEO & R.H. HRUBAN. 1996. Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv. Anal. Pathol. 3: 139-155.
3. 3. STALEY, C.A., J.E. LEE, K.A. CLEARY, J.L. ABBRUZZESE, F.C. AMES, C. FENOGLIO & D.B. EVANS. 1996. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head: Patient survival and patterns of treatment failure. Am. J. Surg. 171: 118-124.
4. 4. HAHN, S.A., M. SCHUTTE, A.T.M. SHAMSUL HOQUE, C.A. MOSKALUK, L.T. DACOSTA, E. ROZENBLUM, C.L. WEINSTEIN, A. FISCHER, C.J. YEO, R.H. HRUBAN & S.E. KERN. 1996. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
5. 5. MASSAGUE, J. 1996. TGF-b signaling: Receptors, transducers, and mad proteins. Cell 85: 947-950.
6. 6. FYNAN, T.M. & M. REISS. 1993. Resistance to inhibition of cell growth by transforming growth factor-b and its role in oncogenesis. Crit. Rev. Oncog. 4: 493-540.
7. 7. GRAU, A.M., L. ZHANG, W. WANG, S. RUAN, D.B. EVANS, A.L. ABBRUZZESE, W. ZHANG & P.J. CHIAO. 1997. Induction of p21 waf1 expression and growth inhibition by transforming growth factor-b involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res. 57: 3929-3934.
8. 8. ZHOU, S., P. BUCKHAULTS, L. ZAWEL, Z. F. BUN, G. RIGGINS, J. LE DAI, S.E. KERN, K.W. KINZLER & B. VOGELSTEIN. 1998. Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc. Natl. Acad. Sci. 95: 2412-2416.
9. 9. KRETZSCHMAR, M. & J. MASSAGUE. 1998. SMADs: Mediators and regulators of TGF-b signaling. Curr. Opin. Genet. Dev. 8: 103-111.
10. 10. ZHANG, Y., T. MUSCI & R. DERYNCK. 1997. The tumor suppressor Smad4/DPC4 as a central mediator of Smad function. Curr. Biol. 7: 270-276.
11. 11. KIM, J., K. JOHNSON, H. J. CHEN, S. CARROLL & A. LAUGHON. 1997. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388: 304-308.
12. 12. CHEN, X., M.J. ROBOCK & M. WHITMAN. 1996. A transcriptional partner for MAD proteins in TGF-b signaling. Nature 383: 691-696.
13. 13. CHEN, X., E. WEISBERG, V, FRIDMACHER, M. WATANABE, G. Naco & M. Whitman. 1997. Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-69.
14. 14. CHEN, Y.G., A. HATA, R.S. LO, D. WOTTON, Y. SHI, N. PAVLETICH & J. MASSAGUE. 1998. Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12: 2144-2152.
15. 15. ZAWEL, L., J.L. DAI, P. BUCKHAULTS, S. ZHOU, K.W. KINZLER, B. BOGELSTEIN & S.E. KERN. 1998. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1: 611-617.
16. 16. ZHANG, Y., X. FENG, R. WE & R. DERYNCK. 1996. Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383: 168-172.
17. 17. YINGLING, J.M., P. DAS, C. SAVAGE, M. ZHANG, R.W. PADGETT & X.F. WANG. 1996. Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth. Proc. Natl. Acad. Sci. USA 93: 8940-8944.
18. 18. LAGNA, G., A. HATA, A. HEMMATI-BRIVANLOU & J. MASSAGUE. 1996. Partnership between DPC4 and SMAD proteins in TGF-b signalling pathways Nature 383: 832-836.
19. 19. FREEMAN, J.W., C.A. MATTINGLY & W.E. STRODEL. 1995. Increased tumorigenicity in the human pancreatic cell line MTA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-b type RII receptor. J. Cell Physiol. 165: 155-163.
20. 20. HAHN, S.A., A.T. HOQUE, C.A. MOSKALUK, L.T. DA COSTA, M. SCHUTTE, E. ROZENBLUM, A.B. SEYMOUR, C.L. WEINSTEIN, C.J. YEO, R.H. HRUBAN & S.E. KERN. 1996. Homozygous deletion map at 18q21.1 in pancreatic cancer. Cancer Res. 56: 490-494.
21. 21. XIONG, Y., G.J. HAMNON, H. ZHANG, D. CASSO, R. KOBAYAASHI & D. BEACH. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
22. 22. DIGIUSEPPE, J.A., M.S. REDSTON, C.J. YEO, S.E. KERN & R.H. HRUBAN. 1995. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am. J. Pathol. 147: 884-888.
23. 23. EL-DEIRY, W.S., T. TOKINO, V.E. VELCULESCU, D.B. LEVY, R. PARSONS, J. M. TRENT, D. LIN, W.E. MERCER, K.W. KINZLER & B. VOGELSTEIN. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
24. 24. MOUSTAKAS, A. & D. KARDASSIS. 1998. Regulation of the human p21/WAF1/Cip1 Promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc. Natl. Acad. Sci. USA 95: 6733-6738.
25. 25. Liu, F., C. POUPONNOT & J. MASSAGUE. 1997. Dual role of the Smad4/DPC4 tumor suppressor in TGFb-inducible transcriptional complexes. Genes & Dev. 11: 5157-3167.
26. 26. WISTZKEY, R.G., A. MEHRA, D.J. SUTHERLAND, L.L. DOBENS, X. LIU, C. DOHRMANN, L. ATTISANO & L.A. RAFTERY. 1998. Medea is a Drosophila Smad4 homolog that is differentially required to potentiate DPP responses. Development 125:1433-1445.